JP2024546129A5 - - Google Patents
Info
- Publication number
- JP2024546129A5 JP2024546129A5 JP2024534711A JP2024534711A JP2024546129A5 JP 2024546129 A5 JP2024546129 A5 JP 2024546129A5 JP 2024534711 A JP2024534711 A JP 2024534711A JP 2024534711 A JP2024534711 A JP 2024534711A JP 2024546129 A5 JP2024546129 A5 JP 2024546129A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- acid sequence
- polypeptide
- seq
- nos
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163291283P | 2021-12-17 | 2021-12-17 | |
| US63/291,283 | 2021-12-17 | ||
| PCT/US2022/053196 WO2023114485A1 (en) | 2021-12-17 | 2022-12-16 | Fusion proteins comprising alpha-l-iduronidase enzymes and methods |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024546129A JP2024546129A (ja) | 2024-12-17 |
| JP2024546129A5 true JP2024546129A5 (cg-RX-API-DMAC7.html) | 2026-01-07 |
Family
ID=85175822
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024534711A Pending JP2024546129A (ja) | 2021-12-17 | 2022-12-16 | アルファ－ｌ－イズロニダーゼ酵素を含む融合タンパク質及びその方法 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20250136963A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4448746A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024546129A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20240119118A (cg-RX-API-DMAC7.html) |
| CN (1) | CN118401660A (cg-RX-API-DMAC7.html) |
| AR (1) | AR128003A1 (cg-RX-API-DMAC7.html) |
| AU (1) | AU2022415476A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3241240A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL313553A (cg-RX-API-DMAC7.html) |
| MX (1) | MX2024007319A (cg-RX-API-DMAC7.html) |
| TW (1) | TW202340459A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2023114485A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW202542190A (zh) | 2023-12-20 | 2025-11-01 | 美商戴納立製藥公司 | 包含酸性α—葡萄糖苷酶之融合蛋白及其方法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20180185495A1 (en) * | 2014-11-10 | 2018-07-05 | Alexion Pharmaceuticals, Inc. | Therapeutic compositions of alpha-l-iduronidase, iduronate-2-sulfatase, and alpha-galactosidase a and methods of use thereof |
| EA039366B1 (ru) * | 2015-06-24 | 2022-01-19 | Джей Си Ар ФАРМАСЬЮТИКАЛЗ КО., ЛТД. | Антитело к рецептору трансферрина человека, проникающее через гематоэнцефалический барьер |
| WO2018152285A1 (en) | 2017-02-17 | 2018-08-23 | Denali Therapeutics Inc. | Transferrin receptor transgenic models |
| CR20200129A (es) | 2017-10-02 | 2020-08-22 | Denali Therapeutics Inc | Proteínas de fusión que comprenden enzimas de terapia de reemplazo de enzimas |
| WO2019246071A1 (en) * | 2018-06-18 | 2019-12-26 | Denali Therapeutics Inc. | Fusion proteins comprising progranulin |
| WO2021158986A1 (en) * | 2020-02-07 | 2021-08-12 | Denali Therapeutics Inc. | Methods for the treatment of hunter syndrome |
-
2022
- 2022-12-16 AU AU2022415476A patent/AU2022415476A1/en active Pending
- 2022-12-16 CA CA3241240A patent/CA3241240A1/en active Pending
- 2022-12-16 IL IL313553A patent/IL313553A/en unknown
- 2022-12-16 US US18/719,958 patent/US20250136963A1/en active Pending
- 2022-12-16 KR KR1020247022697A patent/KR20240119118A/ko active Pending
- 2022-12-16 JP JP2024534711A patent/JP2024546129A/ja active Pending
- 2022-12-16 CN CN202280083088.0A patent/CN118401660A/zh active Pending
- 2022-12-16 MX MX2024007319A patent/MX2024007319A/es unknown
- 2022-12-16 WO PCT/US2022/053196 patent/WO2023114485A1/en not_active Ceased
- 2022-12-16 TW TW111148472A patent/TW202340459A/zh unknown
- 2022-12-16 AR ARP220103478A patent/AR128003A1/es unknown
- 2022-12-16 EP EP22854477.1A patent/EP4448746A1/en active Pending